Research ArticleThe State of the Art
Open Access
Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
Philipp T. Meyer, Sabine Hellwig, Ganna Blazhenets and Jonas A. Hosp
Journal of Nuclear Medicine July 2022, 63 (7) 971-980; DOI: https://doi.org/10.2967/jnumed.121.263085
Philipp T. Meyer
1Department of Nuclear Medicine, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany;
Sabine Hellwig
2Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany; and
Ganna Blazhenets
1Department of Nuclear Medicine, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany;
Jonas A. Hosp
3Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 7
July 1, 2022
Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
Philipp T. Meyer, Sabine Hellwig, Ganna Blazhenets, Jonas A. Hosp
Journal of Nuclear Medicine Jul 2022, 63 (7) 971-980; DOI: 10.2967/jnumed.121.263085
Jump to section
Related Articles
Cited By...
- SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
- Post-COVID-19 Brain [18F] FDG-PET Findings: A Retrospective Single-Center Study in the United States
- Post-COVID-19 Brain [18F] FDG-PET Findings: A Retrospective Single-Center Study in the United States
- Risk of Suicide Attempts and Self-Directed Violence after SARS-CoV-2 Infection: Outcomes from an Emulated Trial of a Nationwide Observational Matched Cohort of US Veterans
- Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19)
- Decreased cerebral blood flow in non-hospitalized adults who self-isolated due to COVID-19